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2Abstract
Objective: We studied the intervention of nitric oxide (NO), prostacyclin (PGI2) and
endothelium-derived hyperpolarizing factor (EDHF) in mediating responses to
acetylcholine in thyroid arteries from euthyroid (E) and methimazole-treated (MT)
patients.
Design and methods: Branches of the superior thyroid artery were obtained from 19 E
patients and 17 MT patients (euthyroid at the time of surgery) undergoing total
thyroidectomy or hemithyroidectomy. Artery rings were suspended in organ baths for
isometric recording of tension.
Results and conclusions: Acetylcholine caused endothelium-dependent relaxation of
greater magnitude in arteries from MT patients (pD2 7.68±0.19 in E and 8.17±0.26 in
MT, P<0.05). The relaxation was unaffected by indomethacin and partially reduced by
the NO synthase inhibitor L-NMMA. This reduction was higher in arteries from MT
patients (50±6 %) as compared to E patients (36±6 %) (P<0.05). Inhibition of K+
channels using apamin combined with charybdotoxin or high K+ solution abolished
the relaxation resistant to L-NMMA and indomethacin. The maximal contractions to
noradrenaline (in percentage of the response to 100 mM KCl) were lower in MT than
in E patients (57±10 and 96±8, respectively, P<0.05). The hyporesponsiveness to
noradrenaline in arteries from MT patients was corrected by L-NMMA. The results
indicate: (1) thyroid arteries from MT patients show increased relaxation to
acethylcholine and decreased contraction to noradrenaline due to overproduction of
NO; (2) EDHF plays a prominent role in acetylcholine-induced relaxation through
activation of Ca2+-activated K+ channels; (3) the abnormal endothelium-dependent
responses in arteries from MT patients are not corrected by medical treatment.
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3Introduction
Hyperthyroidism is associated with marked effects on the cardiovascular system
including high cardiac output, increased heart rate, and a fall in peripheral vascular
resistance (1). In addition, hyperthyroidism is characterized by alterations in vascular
responsiveness. Experiments in aortic rings from hyperthyroid rats show reduced
responses to contractile agents (2-4) and enhanced endothelium-dependent relaxations
to acetylcholine (4) compared to euthyroid rats.
The mechanism by which thyroid dysfunction alters vascular responsiveness is
still unknown. A recent study in rat isolated renal artery rings has shown that after
short treatment (single injection) with triiodothyronine (T3), acetylcholine-induced
relaxations mediated by endothelium-derived nitric oxide (NO) and by the
endothelium-derived hyperpolarizing factor (EDHF) were significantly enhanced
compared to controls.  Following 8 week treatment with T3, EDHF-mediated
relaxation was impaired, whereas NO-mediated relaxation remained enhanced (5).
These results show differences in vascular responses between acute and chronic
hyperthyroidism and indicate that  both NO and EDHF are responsible for the
increased endothelium-dependent relaxation in hyperthyroidism.
In humans, during acetylcholine infusion, forearm blood flow, measured by
plethysmography, increased more in hyperthyroid patients than in control subjects (6).
In addition, untreated hyperthyroid patients showed a more pronounced fall in forearm
blood flow after inhibition of basal NO synthesis by intra-arterial infusion of the NO-
synthase inhibitor NG-monomethyl-L-arginine (L-NMMA). These results in human
resistance vessels strongly suggest that NO might play a key role in the vascular
changes observed in thyroid dysfunction. Moreover, after treatment with the
antithyroid drug methimazole, thyroid hormone levels, basal forearm blood flow, and
4vasodilatation in response to acetylcholine  were restored to normal, thus supporting
the conclusion that thyroid hormone elevation is specifically responsible for the
vascular abnormalities observed in untreated hyperthyroidism (6).
The endothelium-NO system of human thyroid arteries remains largely
unexplored. A recent study from our laboratory has shown that in human thyroid
arteries from multiorgan donors the endothelium modulates responses to acetylcholine
and noradrenaline through the release of NO and EDHF (7). The EDHF component
involved activation of Ca2+-dependent K+ channels sensitive to the K+ channel
blockers charybdotoxin and apamin.  No data are available concerning endothelial
function in thyroid arteries from euthyroid patients and patients with Graves' disease
treated with methimazole. Such data would be relevant  in the understanding of the
regulation of intrathyroidal blood after medical treatment and the mechanisms
underlying the vascular abnormalities in thyroid disease. Accordingly, the aim of the
present study was to extend our previous observations by determining the responses to
acetylcholine and noradrenaline of thyroid arteries from euthyroid patients and from
hyperthyroid patients with Graves' disease after treatment with methimazole.
5Material and methods
Subjects
Tissue samples were obtained from two groups of patients undergoing subtotal
thyroidectomy or hemithyroidectomy. One group included 19 euthyroid (E) patients
(free thyroxine 1.24±0.04 ng/dL, thyroid stimulating hormone 2.8±0.4 mIU/L) affected
by multinodular goiters causing compression and obstructive symptoms (14 women, 5
men; 54±3 years). The other group included 17 patients affected by Graves’ disease
(15 women, 2 men; 44±4 years), who had been hyperthyroid for 4±1.8 months
according to their medical history. Indications for surgery in this group included
appearance of cyclic phases of exacerbation of the disease. The hyperthyroid patients
had received methimazole  for at least 12 months and were euthyroid at the time of
surgery (free thyroxine 1.14±0.04 ng/dL, thyroid stimulating hormone 2.6±0.6
mIU/L). These patients are referred to as methimazole treated (MT) patients. The
study was approved by the ethical committee of our institution and each patient gave
informed written consent.
In vitro experiments
Glandular branches of the superior thyroid artery were removed and cut into rings (3
mm in length, 1 to 1.5 mm outer diameter) and placed in refrigerated (4º C) modified
Krebs Henseleit solution of the following composition (in mmol/l): NaCl, 115; KCl,
4.6; MgCl2·6H2O, 1.2; CaCl2, 2.5; NaHCO3, 25; glucose, 11.1 and disodium EDTA,
0.01. Each artery ring was prepared for isometric tension recording as previously
described.(7) Changes in isometric force were recorded on a Macintosh computer
(Apple Computer, Cupertino, Calif) by use of Chart version 3.4/s software and a
MacLab/8e data adquisition system (ADInstruments, Mountain View, Calif). In some
experiments, the endothelium was removed by inserting a stainless-steel wire into the
6lumen. An optimal resting tension of 2 g was applied. The rings were allowed to attain
a steady level of tension during a 2- to 3-hour accomodation period before testing.
Relaxations to acetylcholine (1nmol/l to 1µmol/l) were investigated in arteries
precontracted with noradrenaline to 40-50 % of the contraction induced by 100 mmol/l
KCl under the following conditions: 1: in the absence of inhibitors (control response);
2: in the presence of indomethacin (10 µmol/l) to inhibit the production of prostacyclin
(PGI2); 3: in the presence of indomethacin and NG-monomethyl-L-arginine (L-
NMMA, 100 µmol/l) to inhibit the production of PGI2 and NO synthase, respectively;
4: in the presence of indomethacin, L-NMMA and KCl (20 mmol/l) to inhibit the
production of PGI2, NO synthase and K+ channel activity; 5: in the presence of
methimazole (1µmol/l). To examine the nature of K+ channel activation, relaxation to
acetylcholine was obtained in the presence of indomethacin plus L-NMMA combined
with one of the following inhibitors: iberiotoxin (0.1µmol/l), an inhibitor of large-
conductance Ca2+-activated K+ channels, charybdotoxin (0.1µmol/l), an inhibitor of
both large- and intermediate-conductance Ca2+-activated K+ channels, apamin
(1 µmol/l), an inhibitor of small-conductance Ca2+-activated K+ channels, and
glibenclamide (10 µmol/l), a selective blocker of ATP-sensitive K+ channels. Control
(in the absence of inhibitors) and experimental (after incubation for 20 minutes with
inhibitors) responses were obtained from separate preparations.
Concentration-response curves for noradrenaline were determined in the absence and
in the presence of L-NMMA (100 µmol/l ).
Chemicals
All substances were purchased from Sigma Chemical Co. (St. Louis, MO). Stock
solutions of the drugs were freshly prepared every day.
7Data analysis
All values are expressed as means ± SEM. Contraction was expressed as a percentage
of the response to KCl (100 mmol/l). Relaxation was expressed as a percentage of
inhibition of noradrenaline-induced contraction. EC50 values (concentration of agonist
producing half-maximum effect) were expressed as pD2 (-log EC50). The pD2 values
were compared by an unpaired t test and two-way analysis of variance (ANOVA). n
values are presented as the number of patients. Statistical significance was accepted at
P<0.05.
8Results
Acetylcholine caused concentration-dependent relaxations which were of greater
magnitude in arteries from MT patients (Fig. 1, Table I). There was no significant
difference in the response to the endothelium-independent vasodilator sodium
nitroprusside (Table I). In endothelium-denuded rings  the relaxant response to
acetylcholine was abolished. L-NMMA reduced acetylcholine-induced relaxation in
endothelium-intact rings; the inhibition was greater in arteries from MT patients (50%
in MT vs 36% in E, P<0.05). Indomethacin did not change the relaxation to
acetylcholine.
The remaining endothelium-dependent relaxation after exposure to L-NMMA and
indomethacin was further reduced by 20 mmol/l KCl or the combination of
charybdotoxin and apamin whereas apamin with iberiotoxin had no significant effects
(Fig. 2). Inhibition of relaxation by charybdotoxin and apamin was greater in arteries
from MT patients compared to E patients (90% in MT versus 65% in E patients,
P<0.05). Incubation with either apamin, charybdotoxin, iberiotoxin or the blocker of
ATP-sensitive K+ channels glibenclamide had no effect on acetylcholine-induced
relaxation (not shown).
There was a marked hyporesponsiveness of thyroid arteries from MT patients to
noradrenaline (Fig. 3, Table I). L-NMMA increased maximal contractile responses in
arteries from the two groups; however, the increment was more pronounced in arteries
from MT patients (135% in MT vs 35% in E, P<0.05). There was no significant
difference in the contractile response to 100 mmol/l KCl between arteries from E and
MT patients (1950±221 mg vs 2092±215 mg; n=12 for each group; P>0.05).
Methimazole had no effect per se in arteries from E and MT patients. This was
assessed by the absence of effects of methimazole (1 µmol/l) on acethylcoline-induced
9relaxation (Table I) and by the lack of relaxing effect (less than 10%) of methimazole
(10 nmol/l to 5 µmol/l) on arteries contracted with noradrenaline.
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Discussion
The present results in human thyroid arteries reveal that the relaxation to acetylcholine
was significantly greater in arteries from MT patients. In addition, the reduction by L-
NMMA of the acetylcholine-induced relaxation was higher in arteries from MT
patients, thus suggesting that a greater release of NO was involved. The remaining
relaxation, insensitive to L-NMMA and indomethacin, may result from the release by
acetylcholine of EDHF (8). The involvement of NO and EDHF in acetylcholine-
induced relaxation has been recently observed in the isolated renal artery from
hyperthyroid rats (5).
Our results in thyroid arteries from patients indicate that the EDHF component
involves activation of Ca2+-dependent K+ channels sensitive to charybdotoxin and
apamin, a finding similar to that observed in thyroid arteries from donors (7). The
nature and mechanisms of action of EDHF remain unknown. Several candidates for
EDHF have been proposed including endothelium-derived K+ ions (9),
epoxyeicosatrienoic acid (10), hydrogen peroxide (11) and C-type natriuretic peptide
(12). In human left internal mammary artery, EDHF is 11,12-epoxyeicosatrienoic acid
produced by one or more isoforms of cytochrome P450 (CYP450), and accounts for
40% of endothelium-dependent relaxation (13). Experiments in  liver microsomes
suggest a metabolism-dependent inhibition of P450 enzymes by methimazole (14,15).
In the present study we did not determine whether cytochrome P450 enzymes play a
role in endothelium -dependent relaxation of human thyroid arteries and therefore
have no direct evidence that long treatment with methimazole inhibited these enzymes.
However, if methimazole was an EDHF inhibitor in our experiments, the acetylcholine
relaxation insensitive to L-NMMA and indomethacin should have been reduced in
thyroid arteries from MT patients.
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An important feature of the present results is that although the hyperthyroid
patients were euthyroid at the time of surgery, the responsiveness of thyroid arteries
was clearly abnormal. This implies that abnormal endothelium-dependent responses of
arteries from MT patients can be observed when plasma levels of thyroid hormones
have been corrected by treatment. The observation, however, does not rule out a
possible relationship between thyroid hormone levels and endothelium dysfunction in
other vascular beds. In relation to this, it has been shown that the abnormal
responsiveness of human forearm resistance vessels of hyperthyroid patients is
corrected when euthyroidism is restored by medical treatment (6). In support of our
results in thyroid arteries, an  increased blood flow of the superior thyroid artery has
been demonstrated in patients with Graves disease, maintained in a euthyroid status
with methimazole, prior to thyroid surgery (16). The increase in blood flow in the
superior thyroid artery is positively correlated with microvessel density (17) and with
vascular endothelial growth factor expression in hyperplasic follicular cells (18).
These previous reports, together with the present results, indicate that vascularity in
the thyroid gland does not parallel the methimazole-induced normalization of thyroid
hormone levels, and that responsiveness of thyroid vessels does not follow the pattern
of forearm resistance vessels. The abnormal response of thyroid vessels could be the
result of sustained vascular expansion and endothelial cell proliferation caused by
exposure to excess thyroid hormones during the period of time preceding medical
therapy. These changes would lead to overproduction of NO and EDHF. In support of
this proposal it has been shown in patients undergoing thyroid surgery that NO
synthase is expressed in thyroid vascular endothelial cells and thyroid follicular cells
and its levels are higher in hyperthyroid patients (euthyroid at the time of surgery)
compared with euthyroid patients (19). Recent experiments   in the rat have shown that
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after 8 weeks treatment with T3, endothelial NO synthase expression was markedly
enhanced in the aorta and was associated with an increase in NO-mediated relaxation
in the renal artery (5). These effects are probably due to the increased fluid shear stress
at the endothelial surface (20). In contrast to the results observed in the rat renal artery
(5) EDHF-mediated relaxation was enhanced  in MT patients. This may also be the
consequence of a chronic elevation in shear stress, as this stimulus is known to
enhance the expression of potassium channels on endothelial cells (21).
We observe a decreased contractile response to noradrenaline in arteries from MT
patients. Inhibition of NO synthase augmented the contractile responses. This effect is
attributed to the inhibition by L-NMMA of the depressant influence of endothelial NO
released by noradrenaline through stimulation of α2 adrenoceptors on endothelial cells
(22) or through indirect mechanisms involving a signal conducted from smooth
muscle to adjacent endothelial cells (23). The magnitude of the effect of L-NMMA on
contraction elicited by noradrenaline was greater in arteries from MT patients thus
indicating increased endothelial NO production. It is possible that EDHF is also
formed after noradrenaline-induced contraction (24). The study of this possibility has
not been attempted in the present report.
The design of our in vitro experiments does not allow to study long-term effects of
methimazole. Under conditions of acute exposure, methimazole failed to induce
changes in contracted and noncontracted arteries. The range of concentrations of
methimazol used (10-8 – 3x10-6 mol/l) include the mean intrathyroid methimazole
concentration (300 ng/g of thyroid tissue) determined, prior to subtotal thyroid
resection, in patients with Graves' disease (euthyroid at the time of surgery) treated
with methimazole for 11.7 months (25).
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In conclusion, the results indicate: (1) thyroid arteries from MT patients (euthyroid
at time of surgery) show increased relaxation to acethylcholine and decreased
contraction to noradrenaline due to overproduction of NO; (2) EDHF plays a
prominent role in acetylcholine-induced relaxation through activation of Ca2+-
activated K+ channels; (3) the abnormal endothelium-dependent responses in arteries
from MT patients are not corrected by medical treatment.
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Table I.- pD2 and maximal responses values for acetylcholine, sodium
nitroprusside and noradrenaline in arteries from euthyroid (E) and methimazole
treated (MT) patients
E MT
Treatment pD2 Emax (%) pD2 Emax (%)
Acetylcholine
     Control 7.68±0.19  80±6  (9) 8.17±0.26†  96±2† (10)
     L-NMMA 7.91±0.35  51±9* (7) 7.47±0.19*  48±8* (7)
     Methimazole 7.58±0.20  82±8  (4) 8.21±0.35†  96±3† (4)
Sodium nitroprusside 8.16±0.46   100 (6) 8.28±0.34    100 (6)
Noradrenaline
     Control 5.83±0.18   96±8 (7) 5.45±0.11†   57±10† (7)
     L-NMMA 6.01±0.10  130±13* (7) 5.53±0.16†  134±15* (7)
pD2 , negative logarithm of molar concentration required to produce half-
maximal response
* P<0.05 versus control.
† P<0.05 versus euthyroid patients.
Number of patients in parenthesis.
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LEGENDS
Figure 1. Effects of endothelium removal (n=9), indomethacin (n=7), and L-NMMA
(n=7) on relaxation to acetylcholine in thyroid arteries from euthyroid (E) and
methimazole treated (MT) patients.
Figure 2. Relaxation to acetylcholine in the absence (control, n=8) and in the presence
of KCl 20 mM (n=5), apamin plus charybdotoxin (n=6) and apamin plus iberiotoxin
(n=6) in thyroid arteries from euthyroid (E) and methimazole treated (MT) patients. L-
NMMA and indomethacin were present throughout.
Figure 3. Contractile responses to noradrenaline in the absence (control, n=7) and in
the presence of L-NMMA (n=7) in thyroid arteries from euthyroid (E) and
methimazole treated (MT) patients.
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